Anti-tumor and Immunomodulation Seaweed Oligosaccharide Ingredient Production Service

The rising demand for marine-derived pharmaceuticals has firmly established seaweed oligosaccharides as next-generation therapeutic candidates, particularly in oncology and immunology. These low-molecular-weight glycans, derived from complex seaweed polysaccharides, exhibit superior bioavailability and potent biological activities, including direct anti-tumor effects and profound immunomodulatory capabilities. CD BioGlyco offers an end-to-end, specialized production service for high-purity seaweed oligosaccharide ingredients, engineered specifically for inclusion in drug development and high-value nutritional formulations. Leveraging decades of specialized expertise, we provide our clients with reliable, pharmaceutical-grade starting materials to accelerate their R&D pipelines.

Key Technologies

The efficacy of seaweed oligosaccharides is fundamentally linked to their precise structural characteristics—molecular weight, degree of sulfation, and monosaccharide sequence. Our technological platform focuses on ultra-precise control over depolymerization and purification to deliver ingredients with maximized bioactivity and batch-to-batch consistency.

Seaweed Oligosaccharide: Unleashing the Next Generation of Immune-Boosting Therapeutics

CD BioGlyco specializes in the targeted production of seaweed oligosaccharides known to exhibit potent anti-tumor and immunomodulatory effects, positioning them as essential components for innovative drug development.

• Oligosaccharides Exhibiting Bioactivity
  • Fucoidan oligosaccharides (FOs): Primarily derived from brown seaweeds (Laminaria, Undaria). Low-molecular-weight FOs are highly valued for their ability to promote cancer cell apoptosis, inhibit angiogenesis, and activate immune cells, specifically natural killer (NK) cells and cytotoxic T-lymphocytes (CTLs).
  • Carrageenan oligosaccharides (COS): Derived from red seaweeds, including λ-, κ-, and ι-carrageenan. Specific low-molecular-weight λ-COS fractions have demonstrated significant immunopotentiating effects, stimulating macrophage phagocytic capacity and the release of pro-inflammatory cytokines like tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ), which indirectly lead to tumor inhibition.
  • Ulvan oligosaccharides (UOs): Extracted from green seaweeds (Ulva species). These sulfated rhamnan compounds have been shown to possess anti-proliferative and antioxidant properties, alongside an ability to modulate immune responses, making them strong candidates for combination therapies.
• Roles in Anti-tumor and Immunomodulatory Drugs
  • Raw Materials/Active Pharmaceutical Ingredients (APIs): For direct use as the primary therapeutic compound in novel anti-cancer or immuno-stimulatory drugs. Their direct mechanisms, such as inducing cancer cell death or blocking metastatic pathways, validate their potential as potent APIs.
  • Excipients and Adjuvants: Due to their excellent biocompatibility, low toxicity, and ability to modulate the immune system, these oligosaccharides are ideal excipients in drug formulations. They can function as adjuvants in chemo- or immunotherapy by boosting the host immune response against the tumor, potentially enhancing the efficacy and reducing the immunosuppressive side-effects of traditional chemotherapy drugs. They also serve as effective materials for drug delivery systems, encapsulating and targeting other therapeutics.

Workflow

Publication Data

Applications

Advantages

Frequently Asked Questions

What level of purity can I expect for my oligosaccharide ingredient?

We guarantee a minimum purity of 98% for target oligosaccharide fractions. Our rigorous chromatographic purification methods and structural analysis ensure you receive a consistent product that minimizes variability in your downstream studies.

How is the bioactivity of the final ingredient confirmed?

While we provide the defined structure and molecular weight, we also offer custom in vitro assays (e.g., macrophage activation, cytokine secretion, or cancer cell proliferation assays) upon request to confirm the anti-tumor or immunomodulatory potency of your specific batch.

Can you produce oligosaccharides from a specific type of seaweed I provide?

Absolutely. We offer flexible production models. While we maintain a reliable supply chain of standard species, we can apply our core technologies to client-provided, verified raw marine biomass to meet unique research needs.

Customer Review

Associated Services

CD BioGlyco is your dedicated partner for producing high-purity, structurally defined Anti-tumor and Immunomodulation Seaweed Oligosaccharide Ingredients. Our unique combination of proprietary enzymatic depolymerization, advanced purification technologies, and decades of glycoscience expertise ensures that your high-value ingredient is delivered with unparalleled precision. Please feel free to contact us for detailed consultations, technical data, and tailored project proposals.